Ascent Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,427
Closed -$899K 164
2024
Q2
$899K Sell
11,427
-198
-2% -$16.2K 0.13% 111
2024
Q1
$1.01M Buy
11,625
+425
+4% +$36.3K 0.15% 109
2023
Q4
$923K Sell
11,200
-539
-5% -$41.1K 0.15% 106
2023
Q3
$920K Buy
11,739
+789
+7% +$66K 0.17% 101
2023
Q2
$965K Sell
10,950
-58
-0.5% -$4.99K 0.17% 102
2023
Q1
$838K Buy
11,008
+1,120
+11% +$91.3K 0.17% 108
2022
Q4
$768K Buy
9,888
+1,548
+19% +$125K 0.17% 107
2022
Q3
$673K Sell
8,340
-1,729
-17% -$155K 0.16% 104
2022
Q2
$897K Buy
+10,069
New +$1.02M 0.2% 96
2015
Q3
Sell
-5,076
Closed -$376K 111
2015
Q2
$376K Hold
5,076
0.21% 82
2015
Q1
$396K Buy
5,076
+367
+8% +$27.8K 0.22% 85
2014
Q4
$340K Sell
4,709
-45
-0.9% -$3.13K 0.2% 88
2014
Q3
$295K Sell
4,754
-29,502
-86% -$1.88M 0.19% 89
2014
Q2
$2.18M Buy
34,256
+415
+1% +$25.2K 1.38% 34
2014
Q1
$2.08M Buy
33,841
+145
+0.4% +$8.45K 1.43% 33
2013
Q4
$1.93M Buy
+33,696
New +$1.91M 1.37% 34

Other funds holding MDT

Ascent Wealth Partners's MDT Position: Q3 2024 in Review

Ascent Wealth Partners sold out of Medtronic (MDT) in Q3 2024, closing a stake of 11,427 shares — an estimated $899K sold.

Ascent Wealth Partners first reported a position in MDT in Q4 2013 and held it in 16 quarters. The position peaked at $2.18M in Q2 2014. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Ascent Wealth Partners reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Ascent Wealth Partners sold 11,427 Medtronic shares in Q3 2024, an estimated $899K.
  • Ascent Wealth Partners first reported a position in Medtronic in Q4 2013 and held it in 16 quarters.
  • Ascent Wealth Partners's Medtronic position peaked at $2.18M in Q2 2014.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Ascent Wealth Partners's 13F filing for Q3 2024, filed 31 Oct 2024.